The discussion of weight management no longer happens without a mention of GLP-1 drugs.
As these treatments have grown in popularity, so too has interest in understanding appetite. Consumers are asking what drives hunger between meals, why cravings hit when they do, and whether there are ways to feel satisfied without a prescription.
Not everyone wants to take drugs for weight management. Price, limited access and personal preference are prompting interest in food-based approaches that support the body’s own hunger and satiety signals, rather than relying on a pharmaceutical intervention.
This shift is creating a new opportunity for dietary fiber. For most of its commercial life, fiber has been associated primarily with digestive health, from regularity and gut comfort to broader benefits such as immunity.
Satiety has rarely been the headline. This is now changing, as GLP-1 treatments have brought the science of appetite and satiety into everyday conversation.
For consumers, the appeal of fiber is clear in the desire to feel fuller for longer, manage hunger between meals and support a more balanced response to food, without relying on prescriptions or injections. For brands, this creates the possibility to build on an ingredient consumers already know and trust, while addressing growing interest in weight management and metabolic health.
The opportunity is to broaden the role fiber can play, moving it from an ingredient associated primarily with digestive health to one that can also be part of the conversation around fullness, satiety and metabolic health. Emerging research is helping explain why, with certain fibers shown to interact with physiological pathways that influence hunger, fullness and the body’s response to food.
The gut-satiety connection
Clinical research is increasingly exploring the link between certain fibers and the body’s own GLP-1 and peptide YY (PYY) response, alongside their effects on post-meal blood glucose.
The connection begins in the gut. Certain soluble fibers can be fermented by the gut microbiota, producing short-chain fatty acids that may help stimulate the release of satiety hormones, such as GLP-1 and PYY. These signals help communicate fullness to the brain and can influence appetite and food intake.
Fiber can also affect the way carbohydrates are digested and absorbed, helping to moderate the rise in blood glucose following a meal. Together, these effects provide a biological rationale for fiber’s role beyond regularity and digestive health, extending into the mechanisms that influence satiety and metabolic response.
There is now a growing scientific case for looking at fiber in a new manner, which is focused both on what it does in the gut and also on how it impacts metabolism after eating.
Soluble fiber built for formulation
This is where Fibersol, ADM/Matsutani’s soluble dietary fiber, can provide an opportunity for product developers. Designed to deliver fiber in a range of everyday products, Fibersol is a digestion-resistant maltodextrin backed by 30 years of clinical research and more than 100 published studies exploring its effects on satiety, metabolic response and digestive health.
With research supporting its potential to increase feelings of fullness, support the body’s natural satiety-related hormone responses and help reduce post-meal blood glucose response, Fibersol gives formulators an opportunity to build on fiber’s established digestive-health credentials while exploring its broader role in satiety and metabolic health.
For brands and product developers, the opportunity is to translate this science into products that fit naturally into consumers’ everyday routines. Fibersol can be incorporated across foods, beverages and dietary supplements, giving formulators flexibility to explore satiety-focused concepts in formats consumers already understand and use.
That could mean developing products positioned around feeling fuller for longer, while retaining the digestive-health benefits consumers already associate with fiber. As interest in non-pharmaceutical approaches to weight and metabolic health continues to grow, ingredients that can bridge established consumer expectations with emerging areas of science may offer a valuable point of differentiation.
Join the conversation
ADM/Matsutani is partnering with NutraIngredients to unpack this topic in a live broadcast, Fuller For Longer: The Science of Fiber, Satiety, and GLP-1, airing 30 September at 10am CDT. The session brings fiber science and formulation strategy together in one conversation for brands and product developers.
Leading the discussion is Gretchen Karcher, senior technical services manager at ADM, whose decade-plus in fiber R&D has made her an important voice for bridging the gap between fiber science and formulation-ready solutions, and who supports the Fibersol portfolio directly.
She’ll be joined by Vaughn Dubow, senior director of product portfolio marketing for Health and Wellness at ADM. He has more than 18 years of experience in the dietary supplement industry, with a particular focus on microbiome solutions including prebiotics, probiotics, postbiotics, and enzymes.
Register now to secure your place: Fuller for Longer – the Science of Fiber, Satiety, and GLP-1 at 10am CDT, 30 September 2026.
